Literature DB >> 22084456

Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.

Meldon Kahan1, Lynn Wilson, Angela Mailis-Gagnon, Anita Srivastava.   

Abstract

OBJECTIVE: To provide family physicians with a practical clinical summary of opioid prescribing for specific populations based on recommendations from the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. QUALITY OF EVIDENCE: Researchers for the guideline conducted a systematic review of the literature, focusing on reviews of the effectiveness and safety of opioids in specific populations. MAIN MESSAGE: Family physicians can minimize the risks of overdose, sedation, misuse, and addiction through the use of strategies tailored to the age and health status of patients. For patients at high risk of addiction, opioids should be reserved for well-defined nociceptive or neuropathic pain conditions that have not responded to first-line treatments. Opioids should be titrated slowly, with frequent dispensing and close monitoring for signs of misuse. Suspected opioid addiction is managed with structured opioid therapy, methadone or buprenorphine treatment, or abstinence-based treatment. Patients with mood and anxiety disorders tend to have a blunted analgesic response to opioids, are at higher risk of misuse, and are often taking sedating drugs that interact adversely with opioids. Precautions similar to those for other high-risk patients should be employed. The opioid should be tapered if the patient's pain remains severe despite an adequate trial of opioid therapy. In the elderly, sedation, falls, and overdose can be minimized through lower initial doses, slower titration, benzodiazepine tapering, and careful patient education. For pregnant women taking daily opioid therapy, the opioids should be slowly tapered and discontinued. If this is not possible, they should be tapered to the lowest effective dose. Opioid-dependent pregnant women should receive methadone treatment. Adolescents are at high risk of opioid overdose, misuse, and addiction. Patients with adolescents living at home should store their opioid medication safely. Adolescents rarely require long-term opioid therapy.
CONCLUSION: Family physicians must take into consideration the patient's age, psychiatric status, level of risk of addiction, and other factors when prescribing opioids for chronic pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084456      PMCID: PMC3215603     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  60 in total

1.  A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.

Authors:  John R M Caplehorn
Journal:  Med J Aust       Date:  2003-11-17       Impact factor: 7.738

2.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

3.  Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene.

Authors:  R I Shorr; M R Griffin; J R Daugherty; W A Ray
Journal:  J Gerontol       Date:  1992-07

4.  A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission.

Authors:  Cynthia O Townsend; Jennifer L Kerkvliet; Barbara K Bruce; Jeffrey D Rome; Michael W Hooten; Connie A Luedtke; John E Hodgson
Journal:  Pain       Date:  2008-09-19       Impact factor: 6.961

5.  Association between mental health disorders, problem drug use, and regular prescription opioid use.

Authors:  Mark D Sullivan; Mark J Edlund; Lily Zhang; Jürgen Unützer; Kenneth B Wells
Journal:  Arch Intern Med       Date:  2006-10-23

6.  Fracture risk associated with the use of morphine and opiates.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  J Intern Med       Date:  2006-07       Impact factor: 8.989

Review 7.  Use of buprenorphine in pregnancy: patient management and effects on the neonate.

Authors:  Rolley E Johnson; Hendrée E Jones; Gabriele Fischer
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

8.  [Use of opioids in the elderly -- pharmacokinetic and pharmacodynamic considerations].

Authors:  E Freye; J V Levy
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2004-09       Impact factor: 0.698

9.  Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances.

Authors:  Jane M Burns; Raymond F Martyres; Danielle Clode; Jennifer M Boldero
Journal:  Med J Aust       Date:  2004-10-04       Impact factor: 7.738

10.  Prescription opioid use among older adults with arthritis or low back pain.

Authors:  Daniel H Solomon; Jerry Avorn; Philip S Wang; George Vaillant; Danielle Cabral; Helen Mogun; Til Stürmer
Journal:  Arthritis Rheum       Date:  2006-02-15
View more
  34 in total

1.  Searching for hope.

Authors:  Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2012-04       Impact factor: 3.275

2.  Correspondence (letter to the editor): Positive history of addiction.

Authors:  Dirk K Wolter
Journal:  Dtsch Arztebl Int       Date:  2013-05       Impact factor: 5.594

3.  Opioid prescribing is a surrogate for inadequate pain management resources.

Authors:  Hillel M Finestone; David N Juurlink; Barry Power; Tara Gomes; Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2016-06       Impact factor: 3.275

4.  Pharmacological Approaches for the Management of Persistent Pain in Older Adults: What Nurses Need to Know.

Authors:  Fabio Guerriero; Ruth Bolier; Janet H Van Cleave; M Cary Reid
Journal:  J Gerontol Nurs       Date:  2016-12-01       Impact factor: 1.254

5.  Markov Logic Networks for Adverse Drug Event Extraction from Text.

Authors:  Sriraam Natarajan; Vishal Bangera; Tushar Khot; Jose Picado; Anurag Wazalwar; Vitor Santos Costa; David Page; Michael Caldwell
Journal:  Knowl Inf Syst       Date:  2016-08-08       Impact factor: 2.822

6.  The authors respond to "Fentanyl patch probably not related to amnesia in case".

Authors:  Ryan G Taylor; Seyed M Mirsattari; Donald H Lee
Journal:  CMAJ       Date:  2019-11-04       Impact factor: 8.262

7.  Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study.

Authors:  Andrea Iaboni; Michael A Campitelli; Susan E Bronskill; Christina Diong; Matthew Kumar; Laura C Maclagan; Tara Gomes; Mina Tadrous; Colleen J Maxwell
Journal:  CMAJ Open       Date:  2019-09-23

8.  Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.

Authors:  Joe Habbouche; Jay Lee; Rena Steiger; James M Dupree; Caitlin Khalsa; Michael Englesbe; Chad Brummett; Jennifer Waljee
Journal:  JAMA Surg       Date:  2018-12-01       Impact factor: 14.766

9.  Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing.

Authors:  Meldon Kahan; Tara Gomes; David N Juurlink; Michael Manno; Lynn Wilson; Angela Mailis-Gagnon; Anita Srivastava; Rhoda Reardon; Irfan A Dhalla; Muhammad M Mamdani
Journal:  Can Fam Physician       Date:  2013-05       Impact factor: 3.275

10.  Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Authors:  Perrine Roux; Maria A Sullivan; Julien Cohen; Lionel Fugon; Jermaine D Jones; Suzanne K Vosburg; Ziva D Cooper; Jeanne M Manubay; Shanthi Mogali; Sandra D Comer
Journal:  Pain       Date:  2013-05-07       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.